Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review.
Jung Yin TsangMatthew SperrinThomas BlakemanRupert A PayneDarren AshcroftPublished in: BMJ open (2024)
Improved strategies are needed to target patients with polypharmacy, which should consider patient perspectives, individual factors and clinical appropriateness. The development of a cross-cutting measure of problematic polypharmacy that consistently incorporates adjustment for multimorbidity may be a valuable next step to address frequent confounding.